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This paper describes the first case of infection with a recently described novel bunyavirus, severe fever with
thrombocytopenia syndrome virus (SFTSV), in Shanghai, China. The case is originally from Chizhou City, Anhui
province within an endemic area for SFTSV. We describe the etiology, epidemiological characteristics, clinical
diagnosis and treatment of this fatal case. This case is unique because major cause of death was renal failure,
whereas other reported cases have been due to hemorrhage. The investigation and response to this case provides
meaningful insight for the early and rapid diagnosis, treatment, prevention and control of severe fever with
thrombocytopenia syndrome virus in non-endemic regions in China and globally.
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A novel member of phlebovirus genus of the Bunyaviridae
family, severe fever with thrombocytopenia syndrome
virus (SFTSV), was first identified in China in 2010 [1,2],
Surveillance data indicate that eastern, central, and north-
east China are the major endemic areas of the virus, al-
though there have been sporadic cases in non-endemic
areas. As suggested by the clinical syndrome it produces
(severe fever with thrombocytopenia syndrome, SFTS),
the key features of this viral infection are a severe systemic
illness characterized by fever and thrombocytopenia.
SFTS mainly occurs in the spring and summer, espe-
cially among middle-aged residents who live in moun-
tainous regions [3]. SFTSV infection results in fever,
thrombocytopenia, gastrointestinal symptoms, and leuko-
cytopenia [4]. The initial fatality rate for SFTS was 30%,
however with improved diagnosis or treatment of the dis-
ease, the fatality rate in China has decreased by 10-15%
according to 2011 surveillance data. These fatalities were
characterized by patients dying from hemorrhage or
multiorgan failure [5].* Correspondence: zayuan@scdc.sh.cn
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reproduction in any medium, provided the orAccording to the Chinese SFTS diagnosis and treatment
guidelines, the case definition for SFTS includes a
temperature above 38°C associated with thrombocytopenia,
and fever with one or more bleeding symptoms (melena,
bleeding gums, skin petechial or ecchymose, conjunctival
hyperemia or hemorrhage symptoms). The case is con-
firmed by virus isolation, the detection of SFTS bunyavirus
RNA, by novel bunyavirus IgG antibody seroconversion,
and/or by a convalescent titer more than four times higher
than in the acute phase [1].
In our analysis, we present the case in terms of infec-
tion, diagnosis and treatment and then discuss the epi-
demiology and virology.Case presentation
The case under consideration in this article is a 40 year-
old female farmer who lived in the countryside near the
hilly areas outside Chizhou city, in Anhui Province,
China, which is one of the central endemic areas. The
patient had given birth by caesarean section in 1999, and
raised her 13 year old in her hometown, while her hus-
band left for work in another city. She had no other
basic conditions or infectious diseases; except for a his-
tory of shistosomiasis in 2008. There was no history of
previous drug or food allergies or blood transfusions.
She was admitted to a hospital in Shanghai (400 km/78
miles from Chizhou) in the middle of May 2012.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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The patient had a sudden onset of fever (reaching a peak
in temperature of 40°C) accompanied by muscle pain on
May 16th 2012. She was reviewed at the local hospital,
admitted and commenced on intravenous antibiotics, but
no clinical improvement was observed. On May 19th, she
was transferred to the hospital in Chizhou where she was
treated with aztreonam and ribavirin, but the high fever
continued. A tick-borne disease was suspected. On May
21st, the patient was transferred to a hospital in Shanghai,
reporting fever, chills, body aches, and diarrhea occurring
five to six times a day. The patient was clinically suspected
of having SFTSV infection, admitted to the ICU (Intensive
Care Unit), was given cefotiam, levodvopropizine, and
other supporting and symptomatic treatments, but did not
improve. The patient became apathetic on May 22nd and
she was given vancomycin and other input platelet ther-
apy, but her condition further deteriorated.
The following day she had a stiff neck, accompanied
by enlarged lymph nodes in the neck, axillary and medias-
tinal regions, and abnormal brain waves on electroenceph-
alogram. On May 25th, the patient was in critical condition
with shortness of breath, hypotension to 88/50 mmHg,
significant oliguria with acute renal failure, severe acidosis,
an abnormal flow index of the liver and kidneys, although
there was no skin bleeding or blood stasis. Thereafter, she
was treated with prednisone, platelet and plasma transfu-
sions, and hemodialysis, but died on the same day (May
25th) of died of multi-organ failure, including kidney andTable 1 Laboratory findings of a confirmed case of infection
Laboratory variables D4 (5.19) D5 (5.20 9:50 AM) D5 (5.20 12:00 AM
WBC (×109/L) 1.32 0.83 0.92
NEUT (×109/L) 0.94 0.57 0.69
LYMPH (×109/L) 0.30 0.23 0.20
PLT (×109/L) 51 40 39
Red cell count (×1012/L) 3.03 3.18 3.09
Hb(g/L) 97 101 95
ALT(U/L) 23 / /
AST(U/L) 62 / /
LDH(U/L) 320 / /
CK(U/L) 154 / /
CK-MB(U/L) 17 / /
CK-MM(U/L) / / /
CR(μ mol/L) 47.2 50.1 /
BUN(mmol/L) 5.71 3.70 /
TT(Second) / / 13
PT(Second) / / 13
APTT(Second) / / 35.50
Positive urine protein / / /
D day of illness, WBC White blood cell, LYMPH Lymphocyte, NEUT neutrophil, PLT pl
transferase, APTT activated partial thromboplastin time, TT thrombm time, LDH lactarespiratory failure, disseminated intravascular coagulation
and septic shock.
Basic laboratory investigations
Laboratory tests showed that the patient’s white cell count
decreased through most of the course of her illness, but
then increased on the day of her death (Table 1). The
platelet counts persistently decreased along with thrombin
times, and activated partial thromboplastin times (APTTs)
were prolonged. Multiorgan dysfunction (including liver
and kidney failure) was evidenced by elevated blood urea
nitrogen (BUN) and hepatic transaminases (alanine ami-
notransferase, ALT; aspartate aminotransferase; AST), lac-
tate dehydrogenase (LDH), and creatine kinase (CK). The
presence of microscopic hematuria and proteinuria were
also documented. These clinical findings are summarized
in Table 1.
On May 25th the results of an arterial blood gas was
consistent with severe metabolic acidosis with respira-
tory compensation, as follows:
pH: 7.17; PCO2: 14.0 mmHg; PO2: 110 mmHg; HCO3
-:
5.10 mmol/L; CO2-CT: 5.5 mmol/L; BE-ecf: -23.4 mmol/L;
SBC: 8.5; BE-b: -21.1 mmol/L; SO2: 97%.
Epidemiology
The patient had several environmental exposures that
may have contributed to her acquisition of SFTSV. She
was engaged in collecting cotton, rice and tea until two
weeks before the onset, and also had a contact historywith SFTSV in Shanghai, China, 2012
) D6 (5.21) D7 (5.22) D8 (5.23) D9 (5.24) D10 (5.25) Death
1.19 / 1.20 / 11.57
0.7 / 0.8 /
0.4 / 0.4 /
35 / 27 / 61
3.33 / 3.34 / 3.8
105 / 105 / 119
72 / / / 254
277 / / / 2321
1411 / / /
495 / / / 1180
/ / / / 196
/ / / / 984
61 / / / 275
3.2 / / / 15.9
/ 24.5 / / >150
/ 13.4 / / 23.4
/ 53.7 / / 140
++++ +++ / /
atelet, HGB hemoglobin, ALT alanme aminotransfcrase, AST aspartate amino-
te dehydrogenase, CK creatine kinase, BUN blood urea nitrogen, CR creatinine.
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local area. She had no skin damage or history of tick
bites. She had had no known exposure to a person with
a similar illness in the countryside, and no similar cases
were found in the local town where the patient lived.
Nineteen people, including three family members and
sixteen medical staff (eleven doctors and five nurses)
came into contact with the patient during the course of
her hospitalization. No secondary cases of SFTS were
found in any of these contacts.
Virology and associated molecular investigations
On May 25th, blood samples collected on the day of death
were sent to Shanghai Municipal Center for Disease
Control and Prevention, and confirmed as SFTSV. Con-
firmation was by real-time reverse transcriptase quantita-
tive PCR [6]. L, S and M segments were sequenced and
analyzed by Mega 5.05. The results showed that the L
sequence of the patient was closely related (96.3–98.7%
nucleotide sequence homology) to the L segment of
SFTSV isolated from other areas in China, including
Jiangsu, Anhui, Shandong and Henan. In contrast, the
L segment only had a 48.7% sequence homology to Rift
Valley fever virus (RVFV), 37.2% to Toscann virus, and
50.4% to Uukuniemi virus (UUKV). The phylogenetic tree
of nuclear acid sequences of the RNA-dependent RNA
polymerase was derived from the L-segment sequence of
previously reported SFTSV strains and that from our pa-
tient. This shows that our patient’s strain and that of other
Chinese SFTSV isolates belong to a single genetic lineage,Figure 1 L gene phylogenetic analysis comparing SFTS
bunyavirus strain from Shanghai and other areas, and other
phlebovirus species downloaded from GenBank. RVFV (Valley fever
virus); SFNV (Sandfly fever Naples virus); and UUKV (Uukuniemi virus).whereas these are all nearly equidistant from the Sandfly
fever and Uukuniemi groups, as previously reported. This
result suggests that SFTSV from the patient has one
genetic lineage and belongs to a novel group in the
phlebovirus genus (see Figure 1).
The homology of the M sequence in this patient was
97.9–99.4% to other SFTSV strains, but showed only
68.2–68.6% similarity to other phleboviruses. The phylo-
genetic tree indicated that all Chinese SFTSV M genes
are clustered together, but are very distantly related to
other phlebovirus groups, such as the Sandfly fever
group, (Rift Valley fever virus, Punta Toro virus, Toscana
virus, Massila virus, and Sandfly fever Sicilian virus), and
the Uukuniemi group (see Figure 2).
The S segment of the patient had 95.0–99.5% hom-
ology to other SFTSV strains, but only 32.0–40.2% simi-
larity to other phleboviruses. The phylogenetic tree was
very similar to the M and L gene analyses (see Figure 3).
There was no difference in the L, S and M segment
mutations between SFTSV strains from the patient who
died and previously reported patients with mild disease.
The study was approved by the Ethical Committee of
the Shanghai Municipal Center for Disease Control and
Prevention.
Conclusions
The clinical symptoms of SFTS are considered to resemble
those of human anaplasmosis, hemorrhagic fever with renal
syndrome, and leptospirosis [2,7-10]. This patient presented
with fever, gastrointestinal symptoms, leucocytopenia andFigure 2 M gene phylogenetic analysis comparing SFTS
bunyavirus strains from Shanghai and other areas, and other
phlebovirus species downloaded from GenBank. RVFV (Valley
fever virus); SFNV (Sand fly fever Naples virus); UUKV (Uukuniemi
virus); SFSV (Sandfly fever Sicilian virus); and PTV (Punta Toro virus).
Figure 3 S gene phylogenetic analysis comparing SFTS
bunyavirus strains from Shanghai and other areas, and other
phlebovirus species downloaded from GenBank. RVFV (Valley
fever virus); SFNV (Sandfly fever Naples virus); UUKV (Uukuniemi
virus); SFSV (Sandfly fever Sicilian virus); and PTV (Punta Toro virus).
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clinical presentation can be differentiated with the use of
basic and specialized laboratory testing, including micros-
copy, nucleic acid detection and sequencing, antigen detec-
tion, virus isolation, and serum antibody testing. The
method of virus acquisition remains to be clearly eluci-
dated. Ticks may serve as one of the candidate vectors of
SFTSV, since the RNA has been detected in Haemaphysalis
longicornis and other tick species [2,11,12]. SFTS, an emer-
ging infectious disease, is progressive and potentially fatal.
The epidemiology, pathogenesis and route of transmission
of this novel disease are still unclear.
Our patient was a 40 year-old female farmer, who had
lived in the hilly areas of Anhui Province, and had no con-
tact with individuals with similar clinical manifestations.
Although she had no history of tick bites, it is likely she
had contact in the fields while harvesting tea and hay. Fur-
ther research is required to determine whether ticks, mos-
quitos, and/or other rodent animals are the vectors and
host species of SFTSV.
Epidemiologic investigation indicated that no contacts
or other villagers were ill with a similar illness. This sug-
gests that person-to-person transmission was limited, al-
though there are reports in other areas of China that
suggested person-to-person transmission [13-15].
The illness duration prior to death in our patient was
ten days, but she was confirmed as a SFTSV infection
only on the day of her death. The laboratory testsshowed that her white blood cell (WBC) count de-
creased during the early stages, but increased on the day
of her death; platelet counts decreased progressively dur-
ing the early stages and were persistently low until the
day of her death. The platelet count decreased to 27×
109/L on the 8th day after the onset of the disease, ac-
companied with coagulopathy (TT, PT and APTT
prolonged), and remained low at 61× 109/L on the day
of death despite platelet transfusions. The elevated WBC
count on the day of death may reflect a systemic inflam-
matory response or possible secondary bacterial infec-
tion. Her hemoglobin (Hb) and red blood cell (RBC)
counts remained stable throughout her illness, consis-
tent with the absence of any hemorrhagic complications
from her thrombocytopenia and coagulation disorder.
Late in the disease SFTSV can invade the heart, liver,
kidney, gastrointestinal tract, and other vital organs, as
well as the bloodstream [16]; our case was not tested for
focal organ involvement. In the case reported here, kidney
and liver dysfunction became more evident, as indicated by
the elevated BUN, creatinine and liver transaminases. Se-
vere renal failure caused persistent oliguria, sodium and
water retention, resulting in respiratory failure and severe
acidosis, and electrolyte disorders. The acute renal failure
was considered the major cause of death. This differenti-
ates this case from other reports of SFTSV infection, where
the major cause of death was hemorrhage [6,10,17,18].
Molecular analysis confirmed that this patient’s SFTSV
had very high homology to previously described strains
from other regions in China. Further analysis of viral se-
quence variation did not reveal any characteristic genetic
changes in our patient’s fatal strain when compared to
genomes of SFTSV isolated from mild cases. This sug-
gests there are not viral genetic factors affecting varia-
tions in virulence and pathogenicity between the fatal
and mild cases.
SFTS was previously reported in seven provinces of
China: Henan, Hubei, Shandong, Anhui, Jiangsu, Liaoning,
and Zhejiang. A national surveillance system for SFTS was
built in these regions and nearby non-epidemic areas. Here
we report a case of death from SFTSV, in a patient who
lived in the Anhui mountain areas (endemic for SFTSV),
but was treated and diagnosed in Shanghai. This SFTSV
case highlights the potential risk to the healthy population
in non-endemic regions, because the patient went to a
large city, Shanghai, for medical treatment, and person-to-
person transmission has been described [15]. It will be a
great challenge for the early diagnosis of SFTS to be car-
ried out in hospitals in non-endemic areas. Earlier diagno-
sis of SFTSV infection will facilitate prompt institution
medical intervention earlier in the course of illness and
will hopefully improve outcomes for patients with SFTSV
infection. In the future, attention should be put on con-
tinuing to strengthen SFTS surveillance and medical staff
Pan et al. Virology Journal 2013, 10:187 Page 5 of 5
http://www.virologyj.com/content/10/1/187training, as well as further standardization and improve-
ment of levels of medical treatment for SFTS, along with
exploration of potential antiviral therapies.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images.
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